ACADIA Pharmaceuticals (ACAD)
(Delayed Data from NSDQ)
$17.07 USD
-0.12 (-0.70%)
Updated Apr 18, 2024 03:59 PM ET
After-Market: $17.08 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | 0.18 |
EPS Last Quarter | 0.28 |
Last EPS Surprise | -12.50% |
ABR | 1.80 |
Earnings ESP
|
-47.87% |
---|---|
Current Year | 0.62 |
Next Year | 1.20 |
EPS (TTM) | -0.38 |
P/E (F1) | 27.56 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 208.75M | 241.04M | 967.49M | 1.06B |
# of Estimates | 7 | 7 | 8 | 8 |
High Estimate | 221.00M | 247.00M | 981.14M | 1.09B |
Low Estimate | 201.30M | 237.48M | 957.24M | 993.00M |
Year ago Sales | 118.46M | 165.24M | 726.44M | 967.49M |
Year over Year Growth Est. | 76.22% | 45.87% | 33.18% | 9.93% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.18 | 0.20 | 0.62 | 1.20 |
# of Estimates | 9 | 7 | 11 | 10 |
Most Recent Consensus | 0.12 | 0.17 | 0.62 | 1.11 |
High Estimate | 1.25 | 0.26 | 0.88 | 1.55 |
Low Estimate | -0.08 | 0.14 | 0.40 | 0.79 |
Year ago EPS | -0.27 | 0.01 | -0.37 | 0.62 |
Year over Year Growth Est. | 166.67% | 1,900.00% | 267.57% | 92.15% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 1 | 2 | 3 | 3 |
Down Last 60 Days | 6 | 6 | 9 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.18 | 0.20 | 0.62 | 1.20 |
7 Days Ago | 0.18 | 0.20 | 0.63 | 1.20 |
30 Days Ago | 0.17 | 0.21 | 0.66 | 1.19 |
60 Days Ago | 0.20 | 0.32 | 1.04 | 1.74 |
90 Days Ago | 0.21 | 0.34 | 1.03 | 1.70 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.10 | 0.18 | 0.71 | 1.14 |
Zacks Consensus Estimate | 0.18 | 0.20 | 0.62 | 1.20 |
Earnings ESP | -47.87% | -11.23% | 13.45% | -4.60% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.28 | -0.40 | 0.01 | -0.27 | NA |
Estimate | 0.32 | -0.43 | -0.12 | -0.21 | NA |
Difference | -0.04 | 0.03 | 0.13 | -0.06 | 0.02 |
Surprise | -12.50% | 6.98% | 108.33% | -28.57% | 18.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more